2019 Q4 Form 10-Q Financial Statement

#000114519719000037 Filed on November 06, 2019

View on sec.gov

Income Statement

Concept 2019 Q4 2019 Q3 2018 Q3
Revenue $209.4M $1.700M $151.1M
YoY Change 26.99% -98.87% 24.08%
Cost Of Revenue $75.30M $69.00M $49.11M
YoY Change 37.91% 40.51% 1.99%
Gross Profit $134.1M $123.1M $102.0M
YoY Change 21.58% 20.69% 38.54%
Gross Profit Margin 64.04% 7241.18% 67.5%
Selling, General & Admin $81.30M $102.3M $72.77M
YoY Change 23.93% 40.65% 41.47%
% of Gross Profit 60.63% 83.14% 71.34%
Research & Development $34.70M $31.30M $22.34M
YoY Change 21.75% 40.13% 10.9%
% of Gross Profit 25.88% 25.43% 21.9%
Depreciation & Amortization $9.120M $7.750M $4.120M
YoY Change 107.27% 88.11% 7.85%
% of Gross Profit 6.8% 6.3% 4.04%
Operating Expenses $116.0M $106.1M $95.10M
YoY Change 23.27% 11.54% 32.87%
Operating Profit $18.10M $17.00M $6.865M
YoY Change 11.5% 147.63% 235.37%
Interest Expense -$9.100M $9.400M $6.846M
YoY Change 71.7% 37.31% -263.0%
% of Operating Profit -50.28% 55.29% 99.72%
Other Income/Expense, Net -$1.800M -$5.012M
YoY Change -64.09% 20.68%
Pretax Income $6.800M $1.100M $1.853M
YoY Change -37.61% -40.64% -187.99%
Income Tax $1.800M $300.0K $194.0K
% Of Pretax Income 26.47% 27.27% 10.47%
Net Earnings $5.000M $800.0K $1.700M
YoY Change -49.49% -52.94% -176.34%
Net Earnings / Revenue 2.39% 47.06% 1.13%
Basic Earnings Per Share $0.08 $0.01 $0.03
Diluted Earnings Per Share $0.08 $0.01 $0.03
COMMON SHARES
Basic Shares Outstanding 61.82M shares 60.74M shares 59.02M shares
Diluted Shares Outstanding 62.34M shares 61.15M shares

Balance Sheet

Concept 2019 Q4 2019 Q3 2018 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $376.1M $605.5M $289.8M
YoY Change 30.18% 108.94% 5.08%
Cash & Equivalents $213.7M $419.9M $126.6M
Short-Term Investments $162.4M $185.6M $163.3M
Other Short-Term Assets $34.00M $23.40M $17.90M
YoY Change 39.92% 30.73% 123.75%
Inventory $101.0M $90.21M $58.05M
Prepaid Expenses $11.04M
Receivables $69.30M $65.05M $69.95M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $591.0M $793.9M $445.7M
YoY Change 28.12% 78.12% 21.77%
LONG-TERM ASSETS
Property, Plant & Equipment $399.4M $355.9M $229.4M
YoY Change 54.57% 55.11% 159.27%
Goodwill $39.80M $39.71M $39.80M
YoY Change 0.51% -0.22% -0.14%
Intangibles
YoY Change
Long-Term Investments $58.40M $31.00M $145.5M
YoY Change -58.52% -78.69%
Other Assets $41.10M $22.90M $2.487M
YoY Change 1704.21% 820.79% 54.09%
Total Long-Term Assets $551.9M $474.5M $440.6M
YoY Change 18.08% 7.69% 228.0%
TOTAL ASSETS
Total Short-Term Assets $591.0M $793.9M $445.7M
Total Long-Term Assets $551.9M $474.5M $440.6M
Total Assets $1.143B $1.268B $886.3M
YoY Change 23.06% 43.11% 77.14%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $54.50M $21.25M $26.85M
YoY Change 113.73% -20.86% -6.29%
Accrued Expenses $103.2M $92.04M $68.17M
YoY Change 14.41% 35.01% 51.83%
Deferred Revenue $3.200M $2.007M $2.210M
YoY Change 166.67% -9.19%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00
YoY Change
Total Short-Term Liabilities $157.7M $113.3M $97.22M
YoY Change 36.3% 16.52% 29.74%
LONG-TERM LIABILITIES
Long-Term Debt $887.9M $985.8M $584.5M
YoY Change 49.98% 68.66% 69.44%
Other Long-Term Liabilities $21.40M $18.77M $6.668M
YoY Change 140.45% 181.48% 7.53%
Total Long-Term Liabilities $909.3M $1.005B $591.2M
YoY Change 51.32% 69.93% 68.35%
TOTAL LIABILITIES
Total Short-Term Liabilities $157.7M $113.3M $97.22M
Total Long-Term Liabilities $909.3M $1.005B $591.2M
Total Liabilities $1.067B $1.118B $688.4M
YoY Change 48.9% 62.39% 61.56%
SHAREHOLDERS EQUITY
Retained Earnings -$672.0M -$677.0M -$693.5M
YoY Change -1.7% -2.38% -0.98%
Common Stock $100.0K $62.00K $59.00K
YoY Change 0.0% 5.08% 1.72%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $75.90M $150.6M $197.9M
YoY Change
Total Liabilities & Shareholders Equity $1.143B $1.268B $886.3M
YoY Change 23.06% 43.11% 77.14%

Cashflow Statement

Concept 2019 Q4 2019 Q3 2018 Q3
OPERATING ACTIVITIES
Net Income $5.000M $800.0K $1.700M
YoY Change -49.49% -52.94% -176.34%
Depreciation, Depletion And Amortization $9.120M $7.750M $4.120M
YoY Change 107.27% 88.11% 7.85%
Cash From Operating Activities $46.93M $31.19M $15.86M
YoY Change 54.17% 96.66% -31.87%
INVESTING ACTIVITIES
Capital Expenditures -$49.92M -$24.07M -$37.62M
YoY Change 43.49% -36.02% 330.43%
Acquisitions
YoY Change
Other Investing Activities -$4.070M $36.25M $11.01M
YoY Change -32.05% 229.25% -4.51%
Cash From Investing Activities -$54.00M $12.19M -$26.62M
YoY Change 32.42% -145.79% -1057.55%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -202.5M 258.2M 1.090M
YoY Change 12632.7% 23588.07% -55.69%
NET CHANGE
Cash From Operating Activities 46.93M 31.19M 15.86M
Cash From Investing Activities -54.00M 12.19M -26.62M
Cash From Financing Activities -202.5M 258.2M 1.090M
Net Change In Cash -209.5M 301.6M -9.670M
YoY Change 1656.24% -3218.72% -133.91%
FREE CASH FLOW
Cash From Operating Activities $46.93M $31.19M $15.86M
Capital Expenditures -$49.92M -$24.07M -$37.62M
Free Cash Flow $96.85M $55.26M $53.48M
YoY Change 48.47% 3.33% 67.02%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
59188758 shares
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
dei Entity Central Index Key
EntityCentralIndexKey
0001145197
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3610000 USD
CY2019Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4174000 USD
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2019Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
61786969 shares
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
59188758 shares
CY2019Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
61786969 shares
CY2018Q3 us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
0 USD
us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
0 USD
us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
0 USD
CY2018Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
14 security
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2019Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2018Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
2700000 USD
dei Local Phone Number
LocalPhoneNumber
600-7000
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2019-09-30
dei Document Transition Report
DocumentTransitionReport
false
CY2019Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
20653000 USD
dei Entity File Number
EntityFileNumber
001-33462
dei Entity Registrant Name
EntityRegistrantName
INSULET CORPORATION
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2019Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
61821566 shares
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
24254000 USD
CY2019Q3 us-gaap Assets Current
AssetsCurrent
793901000 USD
CY2018Q4 us-gaap Assets Current
AssetsCurrent
461286000 USD
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
04-3523891
dei Entity Address Address Line1
EntityAddressAddressLine1
100 Nagog Park
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
419882000 USD
CY2019Q3 us-gaap Long Term Investments
LongTermInvestments
31006000 USD
dei Entity Address City Or Town
EntityAddressCityOrTown
Acton
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
113906000 USD
CY2019Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
185622000 USD
CY2018Q4 us-gaap Long Term Investments
LongTermInvestments
140784000 USD
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
01720
dei City Area Code
CityAreaCode
978
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
dei Security12b Title
Security12bTitle
Common Stock, $0.001 Par Value Per Share
CY2018Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
175040000 USD
CY2019Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
65052000 USD
dei Trading Symbol
TradingSymbol
PODD
dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
63294000 USD
CY2019Q3 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
12485000 USD
CY2018Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
13378000 USD
CY2019Q3 us-gaap Inventory Net
InventoryNet
90207000 USD
CY2018Q4 us-gaap Inventory Net
InventoryNet
71414000 USD
CY2019Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
355865000 USD
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
258379000 USD
CY2019Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
12834000 USD
CY2018Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
10383000 USD
CY2019Q3 us-gaap Goodwill
Goodwill
39713000 USD
CY2018Q4 us-gaap Goodwill
Goodwill
39646000 USD
CY2019Q3 us-gaap Deferred Costs And Other Assets
DeferredCostsAndOtherAssets
35071000 USD
CY2018Q4 us-gaap Deferred Costs And Other Assets
DeferredCostsAndOtherAssets
18266000 USD
CY2019Q3 us-gaap Assets
Assets
1268390000 USD
CY2018Q4 us-gaap Assets
Assets
928744000 USD
CY2019Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
21245000 USD
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
25500000 USD
CY2019Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
92037000 USD
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
90157000 USD
CY2019Q3 us-gaap Liabilities Current
LiabilitiesCurrent
113282000 USD
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
115657000 USD
CY2019Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
985771000 USD
CY2018Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
591978000 USD
CY2019Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
18769000 USD
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
9010000 USD
CY2019Q3 us-gaap Liabilities
Liabilities
1117822000 USD
CY2018Q4 us-gaap Liabilities
Liabilities
716645000 USD
CY2019Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q3 us-gaap Common Stock Value
CommonStockValue
62000 USD
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
59000 USD
CY2019Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
832140000 USD
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
898559000 USD
CY2019Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-676982000 USD
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-683614000 USD
CY2019Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4652000 USD
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2905000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
150568000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
212099000 USD
CY2019Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1268390000 USD
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
928744000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
192115000 USD
CY2018Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
151076000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
528806000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
398916000 USD
CY2019Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
69035000 USD
CY2018Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
49107000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
182612000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
139060000 USD
CY2019Q3 us-gaap Gross Profit
GrossProfit
123080000 USD
CY2018Q3 us-gaap Gross Profit
GrossProfit
101969000 USD
us-gaap Gross Profit
GrossProfit
346194000 USD
us-gaap Gross Profit
GrossProfit
259856000 USD
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
30779000 USD
CY2018Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
22336000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
94997000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
61404000 USD
CY2019Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
47749000 USD
CY2018Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
35952000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
136766000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
105576000 USD
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
27548000 USD
CY2018Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
36816000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
82559000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
81686000 USD
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
106076000 USD
CY2018Q3 us-gaap Operating Expenses
OperatingExpenses
95104000 USD
us-gaap Operating Expenses
OperatingExpenses
314322000 USD
us-gaap Operating Expenses
OperatingExpenses
248666000 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
17004000 USD
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
6865000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
31872000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
11190000 USD
CY2019Q3 us-gaap Interest Expense
InterestExpense
9370000 USD
CY2018Q3 us-gaap Interest Expense
InterestExpense
6846000 USD
us-gaap Interest Expense
InterestExpense
23627000 USD
us-gaap Interest Expense
InterestExpense
22044000 USD
CY2019Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-6451000 USD
CY2018Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-6451000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-10000 USD
CY2019Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-53000 USD
CY2018Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1834000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5924000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5202000 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1130000 USD
CY2018Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1853000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
7718000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-5662000 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
278000 USD
CY2018Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
194000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1086000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
939000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
852000 USD
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
1659000 USD
us-gaap Net Income Loss
NetIncomeLoss
6632000 USD
us-gaap Net Income Loss
NetIncomeLoss
-6601000 USD
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2018Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.11
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2018Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.11
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
60743211 shares
CY2018Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
59016863 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
59986163 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
58779672 shares
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62335679 shares
CY2018Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
61146466 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
61728018 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
58779672 shares
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
852000 USD
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
1659000 USD
CY2018Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-70000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1285000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8560000 USD
us-gaap Net Income Loss
NetIncomeLoss
6632000 USD
us-gaap Net Income Loss
NetIncomeLoss
-6601000 USD
CY2019Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-1858000 USD
CY2018Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
4000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-3032000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-1055000 USD
CY2019Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
35000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-904000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1823000 USD
CY2018Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-66000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1747000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1959000 USD
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-971000 USD
CY2018Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1593000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4885000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
249780000 USD
CY2019Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
17257000 USD
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6626000 USD
CY2019Q3 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-291000 USD
CY2019Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
194401000 USD
CY2019Q3 podd Adjustments To Additional Paidin Capital Capped Call Options
AdjustmentsToAdditionalPaidinCapitalCappedCallOptions
-85360000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
852000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1823000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
150568000 USD
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
179148000 USD
CY2018Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2264000 USD
CY2018Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
16088000 USD
CY2018Q3 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-1159000 USD
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
1659000 USD
CY2018Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-66000 USD
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
197929000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
212099000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
40917000 USD
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
2030000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
20704000 USD
us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-8234000 USD
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
194401000 USD
podd Adjustments To Additional Paidin Capital Capped Call Options
AdjustmentsToAdditionalPaidinCapitalCappedCallOptions
-85360000 USD
us-gaap Net Income Loss
NetIncomeLoss
-6601000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1959000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
20704000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
31205000 USD
us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
-3217000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-6451000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-10000 USD
us-gaap Net Income Loss
NetIncomeLoss
6632000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1747000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
150568000 USD
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
158516000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
12000000 USD
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1481000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
31205000 USD
us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-13845000 USD
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
197929000 USD
us-gaap Net Income Loss
NetIncomeLoss
6632000 USD
us-gaap Net Income Loss
NetIncomeLoss
-6601000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
18784000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
11254000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
24274000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
21790000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2644000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2588000 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
1850000 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-245000 USD
podd Increase Decrease In Accounts Receivable And Unbilled Revenue
IncreaseDecreaseInAccountsReceivableAndUnbilledRevenue
5957000 USD
podd Increase Decrease In Accounts Receivable And Unbilled Revenue
IncreaseDecreaseInAccountsReceivableAndUnbilledRevenue
24581000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
20046000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
25279000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4883000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5258000 USD
podd Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities
IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities
-2550000 USD
podd Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities
IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities
2938000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
847000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-2761000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
2717000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
400000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
51467000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5460000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
114585000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
124855000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
6390000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
2704000 USD
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
63904000 USD
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
145575000 USD
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
165275000 USD
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
129415000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-19604000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-143719000 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
780202000 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 USD
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
453608000 USD
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
6699000 USD
us-gaap Payments For Derivative Instrument Financing Activities
PaymentsForDerivativeInstrumentFinancingActivities
85360000 USD
us-gaap Payments For Derivative Instrument Financing Activities
PaymentsForDerivativeInstrumentFinancingActivities
0 USD
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
42945000 USD
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
13464000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
8234000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
13846000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
275945000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-7081000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-1832000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-674000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
305976000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-146014000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
113906000 USD
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
272577000 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
419882000 USD
CY2018Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
126563000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
10616000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
10711000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
5117000 USD
us-gaap Nature Of Operations
NatureOfOperations
Nature of the Business <div style="line-height:120%;padding-top:6px;text-align:left;text-indent:0px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Insulet Corporation (“Insulet”) is primarily engaged in the development, manufacturing and sale of its proprietary Omnipod</span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">®</sup></span><span style="font-family:inherit;font-size:10pt;"> System, an innovative, discreet and easy-to-use continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System consists of two product lines: the Omnipod Insulin Management System (“Omnipod”), which Insulet has been selling since 2005, and its next generation Omnipod DASH</span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">TM</sup></span><span style="font-family:inherit;font-size:10pt;"> Insulin Management System (“Omnipod DASH” or “DASH”). Insulet began a full market release of Omnipod DASH in the United States at the end of the first quarter of 2019. Collectively, these products are referred to as the “Omnipod System”.</span></div><span style="font-family:inherit;font-size:10pt;">In addition to using the Omnipod System for insulin delivery, Insulet also partners with global pharmaceutical and biotechnology companies to tailor the Omnipod System technology platform for the delivery of their drugs across other therapeutic areas. The majority of Insulet's drug delivery revenue currently consists of sales to Amgen supplying the Neulasta</span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">®</sup></span><span style="font-family:inherit;font-size:10pt;"> Onpro</span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">®</sup></span> kit, an innovative delivery system for Amgen’s white blood cell booster to help reduce the risk of infection during intense chemotherapy.
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="line-height:120%;padding-top:0px;text-indent:0px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Reclassification of Prior Period Amounts</span></div>Certain reclassifications have been made to prior period amounts to conform to the current period financial statement presentation. Software license costs have been reallocated from general and administrative expenses to research and development and sales and marketing expenses based on license usage.
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
192115000 USD
CY2018Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
151076000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
528806000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
398916000 USD
CY2019Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2007000 USD
CY2018Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1184000 USD
CY2019Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1011000 USD
CY2018Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
931000 USD
CY2019Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
3018000 USD
CY2018Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
2115000 USD
CY2019Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
100000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1100000 USD
CY2018Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
600000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
2500000 USD
CY2019Q3 us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
0 USD
CY2019Q3 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
9006000 USD
CY2018Q4 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
7277000 USD
CY2019Q3 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
19282000 USD
CY2018Q4 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
15988000 USD
CY2019Q3 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
28288000 USD
CY2018Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
23265000 USD
CY2019Q3 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
-2300000 USD
us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
6400000 USD
CY2018Q3 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
1800000 USD
us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
5000000.0 USD
CY2019Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
2700000 USD
CY2019Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
14 security
CY2019Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
315017000 USD
CY2018Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
143616000 USD
CY2019Q3 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
21700000 USD
CY2018Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
11898000 USD
CY2019Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
985771000 USD
CY2018Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
591978000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
852000 USD
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
1659000 USD
us-gaap Net Income Loss
NetIncomeLoss
6632000 USD
us-gaap Net Income Loss
NetIncomeLoss
-6601000 USD
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
60743211 shares
CY2018Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
59016863 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
59986163 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
58779672 shares
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62335679 shares
CY2018Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
61146466 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
61728018 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
58779672 shares
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2018Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.11
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.11
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2018Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2019Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10367349 shares
CY2018Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10754004 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10495781 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
14212915 shares
CY2019Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
18605000 USD
CY2018Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
10347000 USD
CY2019Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
40962000 USD
CY2018Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
30222000 USD
CY2019Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
30640000 USD
CY2018Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
30845000 USD
CY2019Q3 us-gaap Inventory Net
InventoryNet
90207000 USD
CY2018Q4 us-gaap Inventory Net
InventoryNet
71414000 USD
CY2018Q4 us-gaap Goodwill
Goodwill
39646000 USD
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
67000 USD
CY2019Q3 us-gaap Goodwill
Goodwill
39713000 USD
CY2019Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
21770000 USD
CY2019Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
8936000 USD
CY2019Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
12834000 USD
CY2018Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
17371000 USD
CY2018Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
6988000 USD
CY2018Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
10383000 USD
CY2019Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
700000 USD
CY2018Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
500000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1900000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1300000 USD
CY2019Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
769000 USD
CY2019Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2641000 USD
CY2019Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2155000 USD
CY2019Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1562000 USD
CY2019Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1100000 USD
CY2019Q3 podd Finite Lived Intangible Assets Amortization Expense Thereafter
FiniteLivedIntangibleAssetsAmortizationExpenseThereafter
4607000 USD
CY2019Q3 podd Finited Lived Intangible Assets Excluding Software In Process Of Development Net
FinitedLivedIntangibleAssetsExcludingSoftwareInProcessOfDevelopmentNet
12834000 USD
CY2018Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
5718000 USD
CY2019Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
43024000 USD
CY2018Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
37822000 USD
CY2019Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
14325000 USD
CY2018Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
14925000 USD
CY2019Q3 us-gaap Accrued Exchange Fee Rebate Current And Noncurrent
AccruedExchangeFeeRebateCurrentAndNoncurrent
5866000 USD
CY2018Q4 us-gaap Accrued Exchange Fee Rebate Current And Noncurrent
AccruedExchangeFeeRebateCurrentAndNoncurrent
2796000 USD
CY2019Q3 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
3123000 USD
CY2018Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
7742000 USD
CY2019Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
25699000 USD
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
26872000 USD
CY2019Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
92037000 USD
CY2018Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
90157000 USD
CY2019Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
6639000 USD
CY2018Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
5503000 USD
CY2018Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
6379000 USD
CY2017Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
5337000 USD
CY2019Q3 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
3271000 USD
CY2018Q3 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
1763000 USD
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
8637000 USD
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
5264000 USD
CY2019Q3 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
3122000 USD
CY2018Q3 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
1548000 USD
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
8228000 USD
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
4883000 USD
CY2019Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
6788000 USD
CY2019Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
6788000 USD
CY2018Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
5718000 USD
CY2019Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
3019000 USD
CY2018Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
2701000 USD
CY2019Q3 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
3769000 USD
CY2018Q4 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
3678000 USD
CY2019Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
6788000 USD
CY2018Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
6379000 USD
CY2015Q2 us-gaap Loss Contingency New Claims Filed Number
LossContingencyNewClaimsFiledNumber
3 lawsuit
CY2015Q2 us-gaap Loss Contingency Claims Dismissed Number
LossContingencyClaimsDismissedNumber
2 lawsuit
CY2019Q3 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2019Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
1200000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
3000000.0 USD
CY2018Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
900000 USD
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
2600000 USD
CY2019Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
1000000.0 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
2600000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
984000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
3628000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
4118000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
3658000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1278000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
2216000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
15882000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1991000 USD
CY2019Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
13891000 USD
CY2019Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
12190000 USD
CY2019Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2341000 USD
CY2019Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
11550000 USD
CY2019Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
13891000 USD
CY2019Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y1M6D
CY2019Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.062
CY2019Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6626000 USD
CY2018Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
16088000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
20704000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
31205000 USD
CY2019Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
45446000 USD
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3077624 shares
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
39.16
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
125640 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
93.16
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1192397 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
34.68
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
99206000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
124198 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
50.58
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1886669 shares
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
44.84
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
226571000 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y7M6D
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1447398 shares
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
38.25
CY2019Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
183351000 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y9M18D
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1835967 shares
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
222101000 USD
CY2019Q3 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
2553000 USD
CY2018Q3 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
2440000 USD
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
7477000 USD
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
7382000 USD
CY2019Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
8202000 USD
CY2018Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
6712000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
22202000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
19840000 USD
CY2019Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
700000 USD
CY2018Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
661000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2072000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1950000 USD
CY2019Q3 us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
2085000 USD
CY2018Q3 us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
2967000 USD
us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
8124000 USD
us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
7128000 USD
CY2019Q3 us-gaap Interest Expense
InterestExpense
9370000 USD
CY2018Q3 us-gaap Interest Expense
InterestExpense
6846000 USD
us-gaap Interest Expense
InterestExpense
23627000 USD
us-gaap Interest Expense
InterestExpense
22044000 USD
CY2019Q3 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
2553000 USD
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
7477000 USD
CY2019Q3 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
8902000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
24274000 USD
CY2019Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
11455000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
31751000 USD
CY2018Q3 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
2440000 USD
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
7382000 USD
CY2018Q3 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
7373000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
21790000 USD
CY2018Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
9813000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
29172000 USD
CY2019Q3 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.246
us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.141
CY2018Q3 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.105
us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.166

Files In Submission

Name View Source Status
0001145197-19-000037-index-headers.html Edgar Link pending
0001145197-19-000037-index.html Edgar Link pending
0001145197-19-000037.txt Edgar Link pending
0001145197-19-000037-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
podd-20190930.xsd Edgar Link pending
podd-20190930_cal.xml Edgar Link unprocessable
podd-20190930_def.xml Edgar Link unprocessable
podd-20190930_lab.xml Edgar Link unprocessable
podd-20190930_pre.xml Edgar Link unprocessable
podd-2019x09x3010q.htm Edgar Link pending
podd-2019x09x3010q_htm.xml Edgar Link completed
podd-exx31120190930x10q.htm Edgar Link pending
podd-exx31220190930x10q.htm Edgar Link pending
podd-exx32120190930x10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending